Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Towne

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Research|August 8, 2012
Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium stateMichele W L Teng, Matthew D Vesely, Helene Duret, et al.
Arthritis Research & Therapy|March 5, 2013
The severity of experimental arthritis is independent of IL-36 receptor signalingCéline Lamacchia, Gaby Palmer, Emiliana Rodriguez, et al.
Rheumatology (Oxford, England)|November 19, 2016
Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseasesAjay Nirula, Jon Nilsen, Paul Klekotka, et al.
Cancer Research|February 22, 2014
Combined anti-CD40 and anti-IL-23 monoclonal antibody therapy effectively suppresses tumor growth and metastasesBianca von Scheidt, Patrick S K Leung, Michelle C R Yong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
IL-1RL2 and its ligands contribute to the cytokine network in psoriasisHal Blumberg, Huyen Dinh, Charles Dean, et al.
Experimental Dermatology|June 13, 2017
Mutation in IL36RN impairs the processing and regulatory function of the interleukin-36-receptor antagonist and is associated with DITRA syndromeElodie Bal, Ai Ching Lim, Min Shen, et al.
The Journal of Experimental Medicine|October 3, 2007
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammationHal Blumberg, Huyen Dinh, Esther S Trueblood, et al.
Plos One|November 12, 2019
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitisCarl L Manthey, Beverley A Moore, Yanqing Chen, et al.
Science (New York, N.Y.)|January 1, 2021
QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasisKwontae You, Lingfei Wang, Chih-Hung Chou, et al.
Immunity|October 4, 2015
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal ImmunoregulationJoseph R Maxwell, Yu Zhang, William A Brown, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Research|August 8, 2012
Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium stateMichele W L Teng, Matthew D Vesely, Helene Duret, et al.
Arthritis Research & Therapy|March 5, 2013
The severity of experimental arthritis is independent of IL-36 receptor signalingCéline Lamacchia, Gaby Palmer, Emiliana Rodriguez, et al.
Rheumatology (Oxford, England)|November 19, 2016
Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseasesAjay Nirula, Jon Nilsen, Paul Klekotka, et al.
Cancer Research|February 22, 2014
Combined anti-CD40 and anti-IL-23 monoclonal antibody therapy effectively suppresses tumor growth and metastasesBianca von Scheidt, Patrick S K Leung, Michelle C R Yong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
IL-1RL2 and its ligands contribute to the cytokine network in psoriasisHal Blumberg, Huyen Dinh, Charles Dean, et al.
Experimental Dermatology|June 13, 2017
Mutation in IL36RN impairs the processing and regulatory function of the interleukin-36-receptor antagonist and is associated with DITRA syndromeElodie Bal, Ai Ching Lim, Min Shen, et al.
The Journal of Experimental Medicine|October 3, 2007
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammationHal Blumberg, Huyen Dinh, Esther S Trueblood, et al.
Plos One|November 12, 2019
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitisCarl L Manthey, Beverley A Moore, Yanqing Chen, et al.
Science (New York, N.Y.)|January 1, 2021
QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasisKwontae You, Lingfei Wang, Chih-Hung Chou, et al.
Immunity|October 4, 2015
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal ImmunoregulationJoseph R Maxwell, Yu Zhang, William A Brown, et al.
Pageof 3